{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:58:49Z","timestamp":1767380329860,"version":"3.48.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study employs bioinformatics analysis with the objective of identifying commonly differentially expressed genes (DEGs) in ulcerative colitis (UC) and rheumatoid arthritis (RA), as well as exploring their underlying molecular mechanisms. By doing so, it aims to provide a theoretical basis for investigating the potential associations between these two diseases and developing novel therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We downloaded multiple gene expression datasets for Rheumatoid Arthritis (RA) and Ulcerative Colitis (UC) from the Gene Expression Omnibus (GEO) database. For RA, GSE77298, GSE12021, and GSE55457 were selected as the training sets, with GSE89408 serving as the validation set. For UC, GSE36807, GSE87473, and GSE92415 were chosen as the training sets, and GSE13367 as the validation set.During data processing, we first merged the RA and UC data from each training set with standardized data, eliminated batch effects, and obtained combined datasets of differentially expressed genes (DEGs). Subsequently, we conducted a cross-analysis of the DEGs from RA and UC to identify commonly up-regulated and down-regulated genes. To gain a deeper understanding of these DEGs, we constructed a protein-protein interaction (PPI) network and identified hub genes.For further analysis of these hub genes, we utilized the GENEMANIA platform to obtain functional annotations and interaction information. Finally, we validated our analysis results using the GSE89408 and GSE13367 datasets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After a thorough analysis of the differentially expressed genes in the cells of patients with rheumatoid arthritis (RA) and ulcerative colitis (UC) we found that genes such as CCR7, CD19, CXCL13, CXCR4, and SELL were significantly up-regulated, suggesting their crucial roles in the pathology of both diseases. This discovery not only underscores the importance of these genes as biomarkers for the differential diagnosis of RA and UC, but also highlights key nodes worthy of further validation. In the future, it may be possible to slow or halt disease progression by modulating the expression of these genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results of this study reveal potential common molecular mechanisms underlying rheumatoid arthritis (RA) and ulcerative colitis (UC). The key target genes CCR7, CD19, CXCL13, CXCR4, and SELL highlight common underlying factors associated with both diseases. Further investigation and exploration of these findings can pave the way for new candidate targets and directions in therapeutic research aimed at treating RA and UC. This study emphasizes the importance of utilizing bioinformatics approaches to uncover the mechanisms of complex diseases, providing a promising pathway for the development of more effective and targeted treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339397","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:56:21Z","timestamp":1767380181000},"page":"e0339397","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of common differential gene expression between rheumatoid arthritis and ulcerative colitis"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-2957","authenticated-orcid":true,"given":"Peng-fei","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-rong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-zheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-sheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"10","key":"pone.0339397.ref001","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"A Finckh","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"pone.0339397.ref002","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","article-title":"Ulcerative colitis: epidemiology, diagnosis, and management","volume":"89","author":"JD Feuerstein","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"10159","key":"pone.0339397.ref003","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"key":"pone.0339397.ref004","article-title":"The clinical features of rheumatoid arthritis","author":"W Grassi","year":"1998","journal-title":"Eur J Radiol"},{"issue":"6","key":"pone.0339397.ref005","first-page":"1037","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"72","author":"JA Rindfleisch","year":"2005","journal-title":"Am Fam Physician"},{"issue":"4","key":"pone.0339397.ref006","first-page":"551","article-title":"One year in review: the pathogenesis of rheumatoid arthritis","volume":"33","author":"V Picerno","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"pone.0339397.ref007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis","volume":"20","author":"Y-Z Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"pone.0339397.ref008","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.disamonth.2019.02.004","article-title":"A comprehensive review and update on ulcerative colitis","volume":"65","author":"M Gajendran","year":"2019","journal-title":"Dis Mon"},{"issue":"11","key":"pone.0339397.ref009","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.mayocp.2014.07.002","article-title":"Ulcerative Colitis","volume":"89","author":"JD Feuerstein","year":"2014","journal-title":"Mayo Clinic Proceedings"},{"issue":"2","key":"pone.0339397.ref010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2478\/rir-2022-0012","article-title":"Inflammatory Bowel Disease: Focus on Enteropathic Arthritis and Therapy","volume":"3","author":"A Barkhodari","year":"2022","journal-title":"Rheumatol Immunol Res"},{"issue":"9","key":"pone.0339397.ref011","article-title":"Relationship between Ulcerative Colitis and Rheumatoid Arthritis: A Review","volume":"11","author":"MG Attalla","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"pone.0339397.ref012","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/14397595.2016.1211229","article-title":"Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study","volume":"27","author":"JM Bae","year":"2017","journal-title":"Mod Rheumatol"},{"key":"pone.0339397.ref013","doi-asserted-by":"crossref","first-page":"611256","DOI":"10.3389\/fimmu.2021.611256","article-title":"The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges","volume":"12","author":"D Noviello","year":"2021","journal-title":"Front Immunol"},{"key":"pone.0339397.ref014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/978-1-0716-1920-9_22","article-title":"RNA-Seq Experiment and Data Analysis","volume":"2418","author":"MHH Withanage","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"33","key":"pone.0339397.ref015","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"ML Halling","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0339397.ref016","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/jcm12041291","article-title":"The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis","volume":"12","author":"Y Cai","year":"2023","journal-title":"J Clin Med"},{"issue":"33","key":"pone.0339397.ref017","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"ML Halling","year":"2017","journal-title":"WJG"},{"key":"pone.0339397.ref018","doi-asserted-by":"crossref","first-page":"572194","DOI":"10.3389\/fgene.2020.572194","article-title":"Identification of Common Differentially Expressed Genes and Potential Therapeutic Targets in Ulcerative Colitis and Rheumatoid Arthritis","volume":"11","author":"Y Chen","year":"2020","journal-title":"Front Genet"},{"issue":"87","key":"pone.0339397.ref019","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adc9584","article-title":"CCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration","volume":"8","author":"J Alanko","year":"2023","journal-title":"Sci Immunol"},{"key":"pone.0339397.ref020","article-title":"Elevated CCL19\/CCR7 Expression During the Disease Process of Primary Sj\u00f6gren\u2019s Syndrome","volume":"10","author":"Z Liu","year":"2019","journal-title":"Front Immunol"},{"issue":"15","key":"pone.0339397.ref021","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.3390\/ijms22158340","article-title":"Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer","volume":"22","author":"EP Brandum","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0339397.ref022","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajpath.2013.04.021","article-title":"Inhibition of CCR7\/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis","volume":"183","author":"F Bos\u00e8","year":"2013","journal-title":"Am J Pathol"},{"issue":"2","key":"pone.0339397.ref023","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13479","article-title":"Rheumatoid arthritis synovial microenvironment induces metabolic and functional adaptations in dendritic cells","volume":"202","author":"M Canavan","year":"2020","journal-title":"Clin Exp Immunol"},{"issue":"15","key":"pone.0339397.ref024","doi-asserted-by":"crossref","first-page":"8340","DOI":"10.3390\/ijms22158340","article-title":"Dendritic Cells and CCR7 Expression: An Important Factor for Autoimmune Diseases, Chronic Inflammation, and Cancer","volume":"22","author":"EP Brandum","year":"2021","journal-title":"Int J Mol Sci"},{"key":"pone.0339397.ref025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cellimm.2005.08.016","article-title":"Expression of chemokine receptors in normal and inflamed human intestine, tonsil, and liver--an immunohistochemical analysis with new monoclonal antibodies from the 8th international workshop and conference on human leucocyte differentiation antigens","volume":"236","author":"F Autschbach","year":"2005","journal-title":"Cell Immunol"},{"issue":"49","key":"pone.0339397.ref026","article-title":"Intercellular adhesion molecule 1 and selectin l play crucial roles in ulcerative colitis","volume":"102","author":"J He","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"pone.0339397.ref027","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrrheum.2009.184","article-title":"CD19: a promising B cell target for rheumatoid arthritis","volume":"5","author":"TF Tedder","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"pone.0339397.ref028","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/cells11071104","article-title":"Increased Frequency of CD4+ Follicular Helper T and CD8+ Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis","volume":"11","author":"DC Anang","year":"2022","journal-title":"Cells"},{"issue":"1","key":"pone.0339397.ref029","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3904\/kjim.1997.12.1.7","article-title":"Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn\u2019s disease","volume":"12","author":"HB Lee","year":"1997","journal-title":"Korean J Intern Med"},{"issue":"1","key":"pone.0339397.ref030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10067-020-05220-2","article-title":"Patients with systemic lupus erythematosus show increased proportions of CD19+CD20- B cells and secretion of related autoantibodies","volume":"40","author":"Q Zhu","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"pone.0339397.ref031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B Cells in Multiple Sclerosis and Related Disorders","volume":"89","author":"G Comi","year":"2020","journal-title":"Annals of Neurology"},{"issue":"4","key":"pone.0339397.ref032","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5","volume":"187","author":"DF Legler","year":"1998","journal-title":"J Exp Med"},{"issue":"10","key":"pone.0339397.ref033","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1002\/art.22939","article-title":"CXCR5- and CCR7-dependent lymphoid neogenesis in a murine model of chronic antigen-induced arthritis","volume":"56","author":"AM Wengner","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"pone.0339397.ref034","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.medcli.2023.01.023","article-title":"Diagnostic role of CXCL13 biomarker in primary Sjogren\u2019s syndrome patients with parotid non-Hodgkin\u2019s lymphoma complication","volume":"160","author":"M Badarinza","year":"2023","journal-title":"Medicina Cl\u00ednica"},{"key":"pone.0339397.ref035","doi-asserted-by":"crossref","first-page":"850998","DOI":"10.3389\/fimmu.2022.850998","article-title":"Role of the CXCL13\/CXCR5 Axis in Autoimmune Diseases","volume":"13","author":"Z Pan","year":"2022","journal-title":"Front Immunol"},{"key":"pone.0339397.ref036","doi-asserted-by":"crossref","first-page":"116037","DOI":"10.1016\/j.bcp.2024.116037","article-title":"CXCL13 promotes TNF-\u03b1 synthesis in rheumatoid arthritis through activating ERK\/p38 pathway and inhibiting miR-330-3p generation","volume":"221","author":"D Achudhan","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"pone.0339397.ref037","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10067-019-04775-z","article-title":"Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis","volume":"39","author":"Y-Q Bao","year":"2020","journal-title":"Clin Rheumatol"},{"key":"pone.0339397.ref038","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients","volume":"77","author":"UP Singh","year":"2016","journal-title":"Cytokine"},{"issue":"1","key":"pone.0339397.ref039","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10238-024-01508-8","article-title":"CXCL13: a common target for immune-mediated inflammatory diseases","volume":"24","author":"L Hui","year":"2024","journal-title":"Clin Exp Med"},{"issue":"6007","key":"pone.0339397.ref040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.1194396","article-title":"Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists","volume":"330","author":"B Wu","year":"2010","journal-title":"Science"},{"issue":"6","key":"pone.0339397.ref041","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302465","article-title":"CXCR4: from B-cell development to B cell-mediated diseases","volume":"7","author":"S Giorgiutti","year":"2024","journal-title":"Life Sci Alliance"},{"key":"pone.0339397.ref042","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fendo.2019.00585","article-title":"The Role of the CXCL12\/CXCR4\/ACKR3 Axis in Autoimmune Diseases","volume":"10","author":"EM Garc\u00eda-Cuesta","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"pone.0339397.ref043","first-page":"1754","article-title":"Plasma level of CXC-chemokine CXCL12 is increased in rheumatoid arthritis and is independent of disease activity and methotrexate treatment","volume":"33","author":"IB Hansen","year":"2006","journal-title":"J Rheumatol"},{"issue":"1","key":"pone.0339397.ref044","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-018-1611-2","article-title":"Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis","volume":"20","author":"E Armas-Gonz\u00e1lez","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"pone.0339397.ref045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.2010.04290.x","article-title":"Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis","volume":"163","author":"S Hosomi","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"pone.0339397.ref046","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s10753-018-0892-6","article-title":"Chronic Inflammation Contributes to Tumor Growth: Possible Role of L-Selectin-Expressing Myeloid-Derived Suppressor Cells (MDSCs)","volume":"42","author":"YV Perfilyeva","year":"2019","journal-title":"Inflammation"},{"key":"pone.0339397.ref047","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: A Major Regulator of Leukocyte Adhesion, Migration and Signaling","volume":"10","author":"A Ivetic","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"pone.0339397.ref048","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02208350","article-title":"Adhesion molecule expression on peripheral blood mononuclear cells in rheumatoid arthritis: positive correlation between the proportion of L-selectin and disease activity","volume":"14","author":"Y Kurohori","year":"1995","journal-title":"Clin Rheumatol"},{"issue":"3","key":"pone.0339397.ref049","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00296-017-3915-y","article-title":"Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis","volume":"38","author":"N Dashti","year":"2018","journal-title":"Rheumatol Int"},{"issue":"12","key":"pone.0339397.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144655","article-title":"Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis","volume":"10","author":"IP Perp\u00e9tuo","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"pone.0339397.ref051","first-page":"482","article-title":"Expression Analysis of Long Noncoding RNA-MALAT1 and Interleukin-6 in Inflammatory Bowel Disease Patients","volume":"22","author":"M Nemati Bajestan","year":"2023","journal-title":"Iran J Allergy Asthma Immunol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339397","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T18:56:33Z","timestamp":1767380193000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339397"}},"subtitle":[],"editor":[{"given":"Srinivas","family":"Mummidi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339397","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}